Diagnosis and management of catamenial seizures: A review

International Journal of Women's Health

Volumn 4, Issue 1, 2012, Pages 535-541

  Verrotti, Alberto ^a   D'Egidio, Claudia ^a   Agostinelli, Sergio ^a   Verrotti, Carla ^b   Pavone, Piero ^c  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Catamenial epilepsy; Estrogens; Neurosteroids; Progesterone

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA4; ACETAZOLAMIDE; ANTICONVULSIVE AGENT; ANTIESTROGEN; BENZODIAZEPINE; CARBAMAZEPINE; CLOBAZAM; CLOMIFENE; CONJUGATED ESTROGEN; EARLY GROWTH RESPONSE FACTOR 3; ELTANOLONE; ESTRADIOL; ESTROGEN; GANAXOLONE; GONADORELIN DERIVATIVE; MEDROXYPROGESTERONE ACETATE; MIFEPRISTONE; NEUROSTEROID; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; PRIMIDONE; PROGESTERONE; PROGESTERONE RECEPTOR; UNINDEXED DRUG; VALPROIC ACID;

ANOVULATION; ANTICONVULSANT ACTIVITY; CATAMENIAL EPILEPSY; CLINICAL ASSESSMENT; COMPLEX PARTIAL SEIZURE; CONTROLLED RELEASE FORMULATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG ABSORPTION; DRUG HALF LIFE; DRUG INDICATION; DRUG INTERMITTENT THERAPY; DRUG MEGADOSE; DRUG TOLERABILITY; DRUG TOLERANCE; DRUG WITHDRAWAL; EPILEPTIC DISCHARGE; EPILEPTIC STATE; ESTRADIOL BLOOD LEVEL; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HORMONE SUBSTITUTION; HUMAN; LOW DRUG DOSE; MENSTRUAL CYCLE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; OSTEOLYSIS; PATHOPHYSIOLOGY; POSTMENOPAUSE; PREMENOPAUSE; PROGESTERONE BLOOD LEVEL; PROPHYLAXIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SEIZURE; SEIZURE SUSCEPTIBILITY; SIDE EFFECT; SIMPLE PARTIAL SEIZURE; TEMPORAL LOBE EPILEPSY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VITAMIN D METABOLISM;

EID: 84867455293     PISSN: None     EISSN: 11791411     Source Type: Journal    
DOI: 10.2147/IJWH.S28872     Document Type: Review

References (73)

1. Reddy DS, Castaneda DC, O'Malley BW, Rogawski MA. Anticonvulsant activity of progesterone and neurosteroids in progesterone receptor knockout mice. J Pharmacol Exp Ther. 2004;310(1):230-239.
2. Velísková J, De Jesus G, Kaur R, Velísek L. Females, their estrogens, and seizures. Epilepsia. 2010;51 Suppl 3:S141-S144.
3. Reddy DS. Role of neurosteroids in catamenial epilepsy. Epilepsy Res. 2004;62(2-3):99-118.
4. Herzog AG. Catamenial epilepsy: definition, prevalence, pathophysiology and treatment. Seizure. 2008;17(2):151-159.
5. Reddy DS. The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy. Epilepsy Res. 2009;85(1):1-30.
6. Duncan S, Read CL, Brodie MJ. How common is catamenial epilepsy? Epilepsia. 1993;34(5):827-831.
7. Kariyawasam SH, Mannapperuma U, Jayasuriya WJ, Weerathunga J, Munasinghe K. Occurrence of menstrual cycle related seizure patterns among epileptic women attending the tertiary neurology clinics of the National Hospital of Sri Lanka. Epilepsy Res. 2009;84(2-3):257-262.
8. Bazán AC, Montenegro MA, Cendes F, Min LL, Guerreiro CA. Menstrual cycle worsening of epileptic seizures in women with symptomatic focal epilepsy. Arq Neuropsiquiatr. 2005;63(3B):751-756.
9. Herzog AG, Harden CL, Liporace J, et al. Frequency of catamenial seizure exacerbation in women with localization-related epilepsy. Ann Neurol. 2004;56(3):431-434.
10. El-Khayat HA, Soliman NA, Tomoum HY, et al. Reproductive hormonal changes and catamenial pattern in adolescent females with epilepsy. Epilepsia. 2008;49(9):1619-1626.
11. Herzog AG, Klein P, Ransil BJ. Three patterns of catamenial epilepsy. Epilepsia. 1997;38(10):1082-1088.
12. Guerrero R, Aso T, Brenner PF, et al. Studies on the pattern of circulating steroids in the normal menstrual cycle. I. Simultaneous assays of progesterone, pregnenolone, dehydroepiandrosterone, testosterone, dihydrotestosterone, androstenedione, oestradiol and oestrone. Acta Endocrinol (Copenh). 1976;81(1):133-149.
13. Redei E, Freeman EW. Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms. Psychoneuroendocrinology. 1995;20(3):259-267.
14. Herzog AG, Fowler KM, Sperling MR, et al; for Progesterone Trial Study Group. Variation of seizure frequency with ovulatory status of menstrual cycles. Epilepsia. 2011;52(10):1843-1848.
15. Quigg M, Fowler KM, Herzog AG; for NIH Progesterone Trial Study Group. Circalunar and ultralunar periodicities in women with partial seizures. Epilepsia. 2008;49(6):1081-1085.
16. Herzog AG, Friedman MN. Menstrual cycle interval and ovulation in women with localization-related epilepsy. Neurology. 2001;57(11):2133-2135.
17. Cummings LN, Giudice L, Morrell MJ. Ovulatory function in epilepsy. Epilepsia. 1995;36(4):355-359.
18. Kalinin VV, Zheleznova EV. Chronology and evolution of temporal lobe epilepsy and endocrine reproductive dysfunction in women: relationships to side of focus and catameniality. Epilepsy Behav. 2007;11(2):185-191.
19. Quigg M, Smithson SD, Fowler KM, Sursal T, Herzog AG; for NIH Progesterone Trial Study Group. Laterality and location influence catamenial seizure expression in women with partial epilepsy. Neurology. 2009;73(3):223-227.
20. McEwen BS, Woolley CS. Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain. Exp Gerontol. 1994;29(3-4):431-436.
21. Herzog AG. Neuroactive properties of reproductive steroids. Headache. 2007;47 Suppl 2:S68-S78.
22. Terasawa E, Timiras PS. Electrical activity during the estrous cycle of the rat: cyclic changes in limbic structures. Endocrinology. 1968;83(2): 207-216.
23. Marcus EM, Watson CW, Goldman PL. Effects of steroids on cerebral electrical activity. Epileptogenic effects of conjugated estrogens and related compounds in the cat and rabbit. Arch Neurol. 1966;15(5):521-532.
24. Woolley CS, McEwen BS. Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. J Neurosci. 1994;14(12):7680-7687.
25. Jacono JJ, Robertson JM. The effects of estrogen, progesterone, and ionized calcium on seizures during the menstrual cycle of epileptic women. Epilepsia. 1987;28(5):571-577.
26. Morrell MJ. Epilepsy in women: the science of why it is special. Neurology. 1999;53(4 Suppl 1):S42-S48.
27. Osborne DM, Frye CA. Estrogen increases latencies to seizures and levels of 5alpha-pregnan-3alpha-ol-20-one in hippocampus of wild-type, but not 5alpha-reductase knockout, mice. Epilepsy Behav. 2009;16(3):411-414.
28. Logothetis J, Harner R, Morrell F, Torres F. The role of estrogens in catamenial exacerbation of epilepsy. Neurology. 1959;9(5):352-360.
29. Hattemer K, Knake S, Reis J, et al. Excitability of the motor cortex during ovulatory and anovulatory cycles: a transcranial magnetic stimulation study. Clin Endocrinol (Oxf). 2007;66(3):387-393.
30. Kalkbrenner KA, Standley CA. Estrogen modulation of NMDA-induced seizures in ovariectomized and non-ovariectomized rats. Brain Res. 2003;964(2):244-249.
31. Velísková J, Velísek L, Galanopoulou AS, Sperber EF. Neuroprotective effects of estrogens on hippocampal cells in adult female rats after status epilepticus. Epilepsia. 2000;41 Suppl 6:S30-S635.
32. Velísková J, Velísek L. Beta-estradiol increases dentate gyrus inhibition in female rats via augmentation of hilar neuropeptide Y. J Neurosci. 2007;27(22):6054-6063.
33. Velísek L, Velísková J. New avenue of research: antiepileptic drug and estradiol neuroprotection in epilepsy. Recent Pat CNS Drug Discov. 2008;3(2):128-137.
34. Hoffman GE, Moore N, Fiskum G, Murphy AZ. Ovarian steroid modulation of seizure severity and hippocampal cell death after kainic acid treatment. Exp Neurol. 2003;182(1):124-134.
35. Weiland NG. Estradiol selectively regulates agonist binding sites on the N-methyl-D-aspartate receptor complex in the CA1 region of the hippocampus. Endocrinology. 1992;131(2):662-668.
36. Joh HD, Searles RV, Selmanoff M, et al. Estradiol alters only GAD67 mRNA levels in ischemic rat brain with no consequent effects on GABA. J Cereb Blood Flow Metab. 2006;26(4):518-526.
37. Ledoux VA, Smejkalova T, May RM, Cooke BM, Woolley CS. Estradiol facilitates the release of neuropeptide Y to suppress hippocampus-dependent seizures. J Neurosci. 2009;29(5):1457-1468.
38. Carroll JC, Rosario ER, Pike CJ. Progesterone blocks estrogen neuroprotection from kainate in middle-aged female rats. Neurosci Lett. 2008;445(3):229-232.
39. Smith SS, Gong QH, Hsu FC, Markowitz RS, French-Mullen JM, Li X. GABA(A) receptor alpha4subunit suppression prevents withdrawal properties of an endogenous steroid. Nature. 1998;392(6679):926-930.
40. Landgren S, Backstrom T, Kalistratov G. The effect of progesterone on the spontaneous interictal spike evoked by the application of penicillin to the cat's cerebral cortex. J Neurol Sci. 1978;36(1):119-133.
41. Kokate TG, Svensson BE, Rogawski MA. Anticonvulsant activity of neurosteroids: correlation with gamma-aminobutyric acid-evoked chloride current potentiation. J Pharmacol Exp Ther. 1994;270(3):1223-1229.
42. Herzog AG. Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology. 1995;45(9):1660-1662.
43. Herzog AG. Progesterone therapy in women with epilepsy: a 3-year follow-up. Neurology. 1999;52(9):1917-1918.
44. Bonuccelli U, Melis GB, Paoletti AM, Fioretti P, Murri L, Muratorio A. Unbalanced progesterone and estradiol secretion in catamenial epilepsy. Epilepsy Res. 1989;3(2):100-106.
45. Reddy DS, Kim HY, Rogawski MA. Neurosteroid withdrawal model of perimenstrual catamenial epilepsy. Epilepsia. 2001;42(3):328-336.
46. Reddy DS, Rogawski MA. Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy. Epilepsia. 2001;42(3):337-344.
47. Frye CA, Rhodes ME, Walf A, Harney J. Progesterone reduces pentylenetetrazol-induced ictal activity of wild-type mice but not those deficient in type I 5alpha-reductase. Epilepsia. 2002;43 Suppl 5:S14-S17.
48. Kokate TG, Juhng KN, Kirkby RD, Llamas J, Yamaguchi S, Rogawski MA. Convulsant actions of the neurosteroid pregnenolone sulfate in mice. Brain Res. 1999;831(1-2):119-124.
49. Edwards HE, Epps T, Carlen PL, MacLusky NJ. Progestin receptors mediate progesterone suppression of epileptiform activity in tetanized hippocampal slices in vitro. Neuroscience. 2000;101(4):895-906.
50. McEwen BS. Invited review: Estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol. 2001;91(6):2785-2801.
51. Belelli D, Lambert JJ. Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat Rev Neurosci. 2005;6(7):565-575.
52. Reddy DS. Is there a physiological role for the neurosteroid THDOC in stress-sensitive conditions? Trends Pharmacol Sci. 2003;24(3): 103-106.
53. Smith SS, Shen H, Gong QH, Zhou X. Neurosteroid regulation of GABA(A) receptors: Focus on the alpha4 and delta subunits. Pharmacol Ther. 2007;116(1):58-76.
54. Follesa P, Serra M, Cagetti E, et al. Allopregnanolone synthesis in cerebellar granule cells: roles in regulation of GABA(A) receptor expression and function during progesterone treatment and withdrawal. Mol Pharmacol. 2000;57(6):1262-1270.
55. Smith SS, Gong QH. Neurosteroid administration and withdrawal alter GABAA receptor kinetics in CA1 hippocampus of female rats. J Physiol. 2005;564(Pt 2):421-436.
56. Roberts DS, Raol YH, Bandyopadhyay S, et al. Egr3stimulation of GABRA4 promoter activity as a mechanism for seizure-induced up-regulation of GABA(A) receptor alpha4subunit expression. Proc Natl Acad Sci U S A. 2005;102(33):11894-11899.
57. Gangisetty O, Reddy DS. The optimization of TaqMan real-time RT-PCR assay for transcriptional profiling of GABA-A receptor subunit plasticity. J Neurosci Methods. 2009;181(1):58-66.
58. Harden CL, Koppel BS, Herzog AG, Nikolov BG, Hauser WA. Seizure frequency is associated with age at menopause in women with epilepsy. Neurology. 2003;61(4):451-455.
59. Nakumura NH, Rosell DR, Akama KT, McEwan BS. Estrogen and ovariectomy regulate mRNA and protein of glutamic acid decarboxylases and cation-chloride cotransporters in the adult rat hippocampus. Neuroendocrinology. 2004;80(5):308-323.
60. McAuley JW, Koshy SJ, Moore JL, Peebles CT, Reeves AL. Characterization and health risk assessment of postmenopausal women with epilepsy. Epilepsy Behav. 2000;1(5):353-355.
61. Abbasi F, Krumholz A, Kittner SJ, Langenberg P. Effects of menopause on seizures in women with epilepsy. Epilepsia. 1999;40(2):205-210.
62. Erel T, Guralp O. Epilepsy and menopause. Arch Gynecol Obstet. 2011;284(3):749-755.
63. Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of antiepileptic drugs. Epilepsia. 2004;45(11):1130-1137.
64. Feldkamp J, Becker A, Witte OW, Scharff D, Scherbaum WA. Long-term anticonvulsant therapy leads to low bone mineral density-evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells. Exp Clin Endocrinol Diabetes. 2000;108(1):37-43.
65. Morrell MJ, Guidice L, Flynn KL, et al. Predictors of ovulatory failure in women with epilepsy. Ann Neurol. 2002;52(6):704-711.
66. Foldvary-Schaefer N, Falcone T. Catamenial epilepsy: pathophysiology, diagnosis, and management. Neurology. 2003;61(6 Suppl 2):S2-S15.
67. Mattson RH, Cramer JA, Caldwell BV, Siconolfi BC. Treatment of seizures with medroxyprogesterone acetate: preliminary report. Neurology. 1984 Sep;34(9):1255-1258.
68. Dana-Haeri J, Richens A. Effect of norethisterone on seizures associated with menstruation. Epilepsia. 1983 Jun;24(3):377-381.
69. Herzog AG, Frye CA. Seizure exacerbation associated with inhibition of progesterone metabolism. Ann Neurol. 2003;53(3):390-391.
70. Herzog AG. Clomiphene therapy in epileptic women with menstrual disorders. Neurology. 1988;38(3):432-434.
71. Laxer K, Blum D, Abou-Khalil BW, et al. Assessment of ganaxolone's anticonvulsant activity using a randomized, double-blind, presurgical trial design. Ganaxolone Presurgical Study Group. Epilepsia. 2000;41(9):1187-1194.
72. Reddy DS, Rogawski MA. Neurosteroid replacement therapy for catamenial epilepsy. Neurotherapeutics. 2009;6(2):392-401.
73. Lim LL, Foldvary N, Mascha E, Lee J. Acetazolamide in women with catamenial epilepsy. Epilepsia. 2001;42(6):746-749.